Key Insights
The Europe Insulin Delivery Devices Market is poised for steady expansion, projected to reach a significant 2.83 Million in value by 2025. This growth is underpinned by a 1.90% CAGR over the forecast period of 2025-2033. A key driver for this market expansion is the escalating prevalence of diabetes across Europe, necessitating efficient and user-friendly insulin management solutions. Advancements in technology, particularly in continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, are revolutionizing patient care and driving adoption of more sophisticated devices like insulin pumps and sensor-augmented pumps. The increasing preference for less invasive and more convenient delivery methods, such as insulin pens and jet injectors, further fuels market momentum. The market is segmented by device type, including insulin pumps, syringes, pens, and jet injectors, alongside technological advancements like CGM and AID, and components such as reservoirs and infusion sets, reflecting a comprehensive approach to insulin delivery.
Europe Insulin Delivery Devices Market Market Size (In Billion)
The competitive landscape features prominent players such as Becton Dickinson and Company, Ypsomed, Novo Nordisk AS, Sanofi, Eli Lilly and Company, Insulet Corporation, and Medtronic PLC, all actively innovating to capture market share. Geographic segmentation highlights the significant presence and growth potential within key European nations like Germany, France, the United Kingdom, and Spain, with "Rest of Europe" also contributing substantially. While the market enjoys strong growth drivers, potential restraints could include the high cost of advanced devices, impacting patient affordability and reimbursement policies, as well as the need for extensive patient training and adherence to complex technological systems. Nevertheless, the ongoing focus on improving diabetes management outcomes and enhancing patient quality of life is expected to sustain a positive growth trajectory for the Europe Insulin Delivery Devices Market.
Europe Insulin Delivery Devices Market Company Market Share
Europe Insulin Delivery Devices Market: Comprehensive Analysis and Future Outlook (2019-2033)
This in-depth report provides a detailed analysis of the Europe Insulin Delivery Devices Market, encompassing historical trends, current dynamics, and future projections from 2019 to 2033. With a focus on market size evolution in million units, technological advancements, and strategic initiatives, this report offers invaluable insights for stakeholders navigating the complex landscape of diabetes management.
Europe Insulin Delivery Devices Market Dynamics & Structure
The Europe Insulin Delivery Devices Market is characterized by a moderate to high level of concentration, with key players like Becton Dickinson and Company, Ypsomed, Novo Nordisk AS, Sanofi, Eli Lilly and Company, Insulet Corporation, and Medtronic PLC holding significant market share. Technological innovation is a primary driver, fueled by the increasing prevalence of diabetes across Europe and the growing demand for user-friendly, efficient, and data-driven insulin management solutions. Regulatory frameworks, such as those established by the European Medicines Agency (EMA), play a crucial role in ensuring product safety and efficacy, influencing market entry and product development timelines. Competitive product substitutes, including traditional vial and syringe methods alongside emerging smart devices, create a dynamic competitive environment. End-user demographics, particularly the aging population and the rising incidence of type 1 and type 2 diabetes, continue to shape market demand. Mergers and acquisitions (M&A) trends are notable, with companies strategically acquiring innovative technologies or expanding their geographical reach to strengthen their market position. For instance, the M&A landscape indicates a consolidation trend as companies aim to leverage combined expertise and expand their product portfolios. The market is also witnessing a rise in partnerships and collaborations aimed at accelerating the development of integrated diabetes management systems.
- Market Concentration: Dominated by a few major global players, with a growing presence of specialized technology providers.
- Technological Innovation: Driven by advancements in connectivity, automation, and miniaturization of devices.
- Regulatory Frameworks: Strict adherence to EMA guidelines influences product approvals and market access.
- Competitive Landscape: Intense competition between established players and innovative startups offering novel solutions.
- End-User Demographics: Increasing diabetes prevalence and a growing demand for patient-centric solutions.
- M&A Trends: Strategic acquisitions and partnerships to gain competitive advantages and expand product offerings.
Europe Insulin Delivery Devices Market Growth Trends & Insights
The Europe Insulin Delivery Devices Market is poised for significant expansion, driven by an increasing diabetic population and a growing adoption of advanced diabetes management technologies. The market size, estimated at xx million units in the base year 2025, is projected to witness a robust Compound Annual Growth Rate (CAGR) of approximately X% throughout the forecast period (2025–2033). This growth is underpinned by a rising awareness of the benefits of proactive diabetes management and the increasing affordability and accessibility of sophisticated insulin delivery systems. Technological disruptions, particularly in the realm of continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, are reshaping patient care paradigms. These advancements are moving away from reactive insulin adjustments towards proactive, data-driven management, significantly improving glycemic control and reducing the burden of diabetes on individuals. Consumer behavior shifts are evident, with a growing preference for connected devices that offer personalized insights, convenience, and improved quality of life. Patients are increasingly seeking solutions that integrate seamlessly into their daily routines, empowering them to actively participate in their diabetes management. The penetration of advanced insulin pumps and smart pens is expected to surge as healthcare providers and patients recognize their efficacy in achieving better therapeutic outcomes compared to traditional methods. The shift towards telehealth and remote patient monitoring further accentuates the demand for connected insulin delivery devices. The overall market penetration of advanced insulin delivery devices is anticipated to reach approximately XX% by 2033.
Dominant Regions, Countries, or Segments in Europe Insulin Delivery Devices Market
Within the Europe Insulin Delivery Devices Market, Insulin Pumps are emerging as the dominant device segment, projected to account for over xx% of the market value by 2033. This dominance is driven by their superior ability to provide continuous and basal insulin delivery, mimicking the natural function of the pancreas. Furthermore, the integration of Automated Insulin Delivery (AID) systems is revolutionizing this segment, offering a more sophisticated approach to diabetes management. Countries like Germany, the United Kingdom, France, and Italy are leading the adoption of advanced insulin delivery devices due to their robust healthcare infrastructures, higher disposable incomes, and proactive diabetes management initiatives.
Device Segment Dominance:
- Insulin Pumps: Leading growth due to advanced functionalities like basal/bolus delivery and integration with AID systems. Market share expected to exceed xx% by 2033.
- Insulin Pens: Steady growth driven by convenience and portability, particularly for type 2 diabetes management.
- Insulin Syringes: Gradual decline in market share, superseded by more advanced and user-friendly alternatives.
- Jet Injectors: Niche market, with limited growth potential compared to other segments.
Technology Segment Leadership:
- Automated Insulin Delivery (AID): Experiencing the fastest growth, driven by partnerships and technological advancements that offer closed-loop systems.
- Sensor-Augmented Insulin Pumps: High adoption rates due to their ability to combine pump therapy with CGM data for improved control.
- Continuous Glucose Monitoring (CGM): Integral to AID and sensor-augmented pumps, driving overall market expansion.
Component Significance:
- Insulin Pump Device: The core component driving demand within the insulin pump segment.
- Infusion Sets: Essential consumables, with innovation focused on comfort and ease of use.
- Reservoir: Critical component for insulin storage, with advancements in capacity and ease of refilling.
Regional Leadership:
- Germany: Strong market presence driven by advanced healthcare policies and high patient awareness.
- United Kingdom: Growing adoption of connected diabetes technologies and a supportive regulatory environment.
- France: Increasing investment in diabetes research and technology adoption.
- Italy: Expanding market due to a rising incidence of diabetes and increasing healthcare expenditure.
The dominance of insulin pumps, particularly those integrated with AID technology, reflects a broader trend towards personalized and automated diabetes management solutions, with Western European countries spearheading this transformation.
Europe Insulin Delivery Devices Market Product Landscape
The Europe Insulin Delivery Devices Market is characterized by continuous product innovation, focusing on enhanced user experience, improved efficacy, and seamless integration with digital health platforms. Insulin pumps are evolving beyond basic delivery to include advanced algorithms for automated insulin dosing, such as Medtronic's MiniMed 770G system with its My Insights feature, offering personalized data-driven recommendations for diabetes management. Insulin pens are incorporating smart features, enabling users to track doses and communicate with healthcare providers. The development of hybrid closed-loop systems, like the partnership between CamDiab and Ypsomed, exemplifies the trend towards connected solutions that leverage continuous glucose monitoring data to automatically adjust insulin delivery, minimizing user intervention and improving glycemic control. These innovations are aimed at reducing the burden of daily diabetes management, improving patient adherence, and ultimately enhancing long-term health outcomes. The focus is on creating intuitive, discreet, and highly effective devices that empower individuals to live fuller lives with diabetes.
Key Drivers, Barriers & Challenges in Europe Insulin Delivery Devices Market
The Europe Insulin Delivery Devices Market is propelled by several key drivers. The rising global prevalence of diabetes, coupled with increasing awareness and diagnosis rates, forms the bedrock of market growth. Technological advancements, particularly in miniaturization, connectivity, and artificial intelligence, are leading to the development of more sophisticated and user-friendly devices. Growing patient preference for home-based diabetes management and self-care solutions further fuels demand. Favorable reimbursement policies in several European nations also contribute significantly to market expansion by improving affordability.
However, the market faces significant barriers and challenges. The high cost of advanced insulin delivery devices can be a substantial restraint, particularly in countries with limited healthcare budgets or reimbursement coverage. Stringent regulatory approval processes, although crucial for safety, can lead to prolonged market entry timelines. Integration challenges with existing healthcare IT systems and the need for extensive patient and healthcare professional training also pose hurdles. Furthermore, data privacy and security concerns associated with connected devices require robust solutions to maintain patient trust. Supply chain complexities and potential disruptions can impact product availability.
Emerging Opportunities in Europe Insulin Delivery Devices Market
Emerging opportunities in the Europe Insulin Delivery Devices Market lie in the continued development and widespread adoption of closed-loop and automated insulin delivery systems, offering unprecedented precision in glucose management. The expansion of integrated diabetes management platforms, which combine insulin delivery with continuous glucose monitoring and data analytics, presents a significant avenue for growth. Untapped markets within Eastern Europe, with improving healthcare infrastructures and increasing diabetes awareness, offer substantial potential. Furthermore, the development of more affordable and accessible insulin delivery solutions tailored for diverse patient populations, including children and individuals with limited technological literacy, represents a key growth area. The increasing focus on preventative care and personalized medicine will drive demand for devices that offer predictive insights and proactive interventions.
Growth Accelerators in the Europe Insulin Delivery Devices Market Industry
Growth accelerators in the Europe Insulin Delivery Devices Market are primarily driven by rapid technological breakthroughs and strategic market expansion initiatives. The relentless innovation in artificial intelligence and machine learning is enabling the development of smarter, more adaptive insulin delivery systems that can predict glucose trends and automate insulin adjustments. Strategic partnerships between device manufacturers, pharmaceutical companies, and digital health providers are crucial for creating integrated ecosystems that offer comprehensive diabetes management solutions. Furthermore, increasing government initiatives and public health campaigns focused on diabetes awareness and management are creating a more conducive market environment. The growing demand for telehealth and remote patient monitoring services directly supports the adoption of connected insulin delivery devices.
Key Players Shaping the Europe Insulin Delivery Devices Market Market
- Becton Dickinson and Company
- Ypsomed
- Novo Nordisk AS
- Sanofi
- Eli Lilly and Company
- Insulet Corporation
- Medtronic PLC
Notable Milestones in Europe Insulin Delivery Devices Market Sector
- October 2022: Medtronic launched My Insights for its MiniMed 770G system, offering personalized, data-driven tips and reminders via email to aid diabetes management, marking a significant step in personalized diabetes care.
- April 2022: CamDiab and Ypsomed partnered to develop and commercialize an integrated automated insulin delivery (AID) system, connecting Abbott's FreeStyle Libre 3 sensor with CamDiab's CamAPS FX app and Ypsomed's mylife YpsoPump for automated insulin delivery based on real-time glucose data.
In-Depth Europe Insulin Delivery Devices Market Market Outlook
The Europe Insulin Delivery Devices Market is poised for substantial future growth, driven by an ongoing wave of technological innovation and increasing patient-centricity in healthcare. The continued advancement of automated and closed-loop insulin delivery systems will redefine diabetes management, offering individuals greater autonomy and improved glycemic control. Strategic collaborations between device manufacturers, sensor providers, and software developers are expected to create seamless, integrated platforms that empower users with personalized insights and predictive analytics. The market is also likely to witness increased penetration in emerging European economies as healthcare infrastructure improves and diabetes awareness rises. The future outlook emphasizes devices that not only deliver insulin effectively but also actively contribute to the overall well-being and quality of life for individuals living with diabetes, making self-management more intuitive and less burdensome.
Europe Insulin Delivery Devices Market Segmentation
-
1. Device
- 1.1. Insulin Pumps
- 1.2. Insulin Syringes
- 1.3. Insulin Pens
- 1.4. Jet Injectors
-
2. Technology
- 2.1. Continuous Glucose Monitoring
- 2.2. Automated Insulin Delivery
- 2.3. Sensor-Augmented Insulin Pumps
-
3. Components
- 3.1. Insulin Pump Device
- 3.2. Reservoir
- 3.3. Infusion Sets
Europe Insulin Delivery Devices Market Segmentation By Geography
- 1. France
- 2. Germany
- 3. Italy
- 4. Russia
- 5. Spain
- 6. United Kingdom
- 7. Rest of Europe
Europe Insulin Delivery Devices Market Regional Market Share
Geographic Coverage of Europe Insulin Delivery Devices Market
Europe Insulin Delivery Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 1.90% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. ; The Rise in Global Prevalence of Cases of Obesity due to Modern Sedentary Lifestyles; Rise in Awareness and Disposable Income in Developed Economies
- 3.3. Market Restrains
- 3.3.1 ; Highly Cost of Branded Products in Emerging Countries; Severe Adverse Associated with Medication Including Seizures
- 3.3.2 Suicidal Attempts and Even Death; Adoption of Traditional Yoga and Herbal Products
- 3.4. Market Trends
- 3.4.1. Insulin Pump segment is expected to witness highest growth during the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Device
- 5.1.1. Insulin Pumps
- 5.1.2. Insulin Syringes
- 5.1.3. Insulin Pens
- 5.1.4. Jet Injectors
- 5.2. Market Analysis, Insights and Forecast - by Technology
- 5.2.1. Continuous Glucose Monitoring
- 5.2.2. Automated Insulin Delivery
- 5.2.3. Sensor-Augmented Insulin Pumps
- 5.3. Market Analysis, Insights and Forecast - by Components
- 5.3.1. Insulin Pump Device
- 5.3.2. Reservoir
- 5.3.3. Infusion Sets
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. France
- 5.4.2. Germany
- 5.4.3. Italy
- 5.4.4. Russia
- 5.4.5. Spain
- 5.4.6. United Kingdom
- 5.4.7. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Device
- 6. France Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Device
- 6.1.1. Insulin Pumps
- 6.1.2. Insulin Syringes
- 6.1.3. Insulin Pens
- 6.1.4. Jet Injectors
- 6.2. Market Analysis, Insights and Forecast - by Technology
- 6.2.1. Continuous Glucose Monitoring
- 6.2.2. Automated Insulin Delivery
- 6.2.3. Sensor-Augmented Insulin Pumps
- 6.3. Market Analysis, Insights and Forecast - by Components
- 6.3.1. Insulin Pump Device
- 6.3.2. Reservoir
- 6.3.3. Infusion Sets
- 6.1. Market Analysis, Insights and Forecast - by Device
- 7. Germany Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Device
- 7.1.1. Insulin Pumps
- 7.1.2. Insulin Syringes
- 7.1.3. Insulin Pens
- 7.1.4. Jet Injectors
- 7.2. Market Analysis, Insights and Forecast - by Technology
- 7.2.1. Continuous Glucose Monitoring
- 7.2.2. Automated Insulin Delivery
- 7.2.3. Sensor-Augmented Insulin Pumps
- 7.3. Market Analysis, Insights and Forecast - by Components
- 7.3.1. Insulin Pump Device
- 7.3.2. Reservoir
- 7.3.3. Infusion Sets
- 7.1. Market Analysis, Insights and Forecast - by Device
- 8. Italy Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Device
- 8.1.1. Insulin Pumps
- 8.1.2. Insulin Syringes
- 8.1.3. Insulin Pens
- 8.1.4. Jet Injectors
- 8.2. Market Analysis, Insights and Forecast - by Technology
- 8.2.1. Continuous Glucose Monitoring
- 8.2.2. Automated Insulin Delivery
- 8.2.3. Sensor-Augmented Insulin Pumps
- 8.3. Market Analysis, Insights and Forecast - by Components
- 8.3.1. Insulin Pump Device
- 8.3.2. Reservoir
- 8.3.3. Infusion Sets
- 8.1. Market Analysis, Insights and Forecast - by Device
- 9. Russia Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Device
- 9.1.1. Insulin Pumps
- 9.1.2. Insulin Syringes
- 9.1.3. Insulin Pens
- 9.1.4. Jet Injectors
- 9.2. Market Analysis, Insights and Forecast - by Technology
- 9.2.1. Continuous Glucose Monitoring
- 9.2.2. Automated Insulin Delivery
- 9.2.3. Sensor-Augmented Insulin Pumps
- 9.3. Market Analysis, Insights and Forecast - by Components
- 9.3.1. Insulin Pump Device
- 9.3.2. Reservoir
- 9.3.3. Infusion Sets
- 9.1. Market Analysis, Insights and Forecast - by Device
- 10. Spain Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Device
- 10.1.1. Insulin Pumps
- 10.1.2. Insulin Syringes
- 10.1.3. Insulin Pens
- 10.1.4. Jet Injectors
- 10.2. Market Analysis, Insights and Forecast - by Technology
- 10.2.1. Continuous Glucose Monitoring
- 10.2.2. Automated Insulin Delivery
- 10.2.3. Sensor-Augmented Insulin Pumps
- 10.3. Market Analysis, Insights and Forecast - by Components
- 10.3.1. Insulin Pump Device
- 10.3.2. Reservoir
- 10.3.3. Infusion Sets
- 10.1. Market Analysis, Insights and Forecast - by Device
- 11. United Kingdom Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Device
- 11.1.1. Insulin Pumps
- 11.1.2. Insulin Syringes
- 11.1.3. Insulin Pens
- 11.1.4. Jet Injectors
- 11.2. Market Analysis, Insights and Forecast - by Technology
- 11.2.1. Continuous Glucose Monitoring
- 11.2.2. Automated Insulin Delivery
- 11.2.3. Sensor-Augmented Insulin Pumps
- 11.3. Market Analysis, Insights and Forecast - by Components
- 11.3.1. Insulin Pump Device
- 11.3.2. Reservoir
- 11.3.3. Infusion Sets
- 11.1. Market Analysis, Insights and Forecast - by Device
- 12. Rest of Europe Europe Insulin Delivery Devices Market Analysis, Insights and Forecast, 2020-2032
- 12.1. Market Analysis, Insights and Forecast - by Device
- 12.1.1. Insulin Pumps
- 12.1.2. Insulin Syringes
- 12.1.3. Insulin Pens
- 12.1.4. Jet Injectors
- 12.2. Market Analysis, Insights and Forecast - by Technology
- 12.2.1. Continuous Glucose Monitoring
- 12.2.2. Automated Insulin Delivery
- 12.2.3. Sensor-Augmented Insulin Pumps
- 12.3. Market Analysis, Insights and Forecast - by Components
- 12.3.1. Insulin Pump Device
- 12.3.2. Reservoir
- 12.3.3. Infusion Sets
- 12.1. Market Analysis, Insights and Forecast - by Device
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2025
- 13.2. Company Profiles
- 13.2.1 Becton Dickinson and Company
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 Ypsomed
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Novo Nordisk AS
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Other
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Sanofi
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Eli Lilly and Company
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 Insulet Corporation
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Medtronic PLC
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Europe Insulin Delivery Devices Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: Europe Insulin Delivery Devices Market Share (%) by Company 2025
List of Tables
- Table 1: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 2: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 3: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 4: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 5: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 6: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 7: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Region 2020 & 2033
- Table 8: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 10: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 11: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 12: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 13: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 14: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 15: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 18: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 19: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 20: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 21: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 22: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 23: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 24: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 25: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 26: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 27: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 28: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 29: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 30: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 31: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 32: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 33: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 34: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 35: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 36: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 37: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 38: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 39: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 40: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 41: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 42: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 43: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 44: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 45: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 46: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 47: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 48: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 49: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 50: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 51: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 52: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 53: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 54: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 55: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 56: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 57: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Device 2020 & 2033
- Table 58: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Device 2020 & 2033
- Table 59: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Technology 2020 & 2033
- Table 60: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Technology 2020 & 2033
- Table 61: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Components 2020 & 2033
- Table 62: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Components 2020 & 2033
- Table 63: Europe Insulin Delivery Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 64: Europe Insulin Delivery Devices Market Volume K Unit Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Insulin Delivery Devices Market?
The projected CAGR is approximately 1.90%.
2. Which companies are prominent players in the Europe Insulin Delivery Devices Market?
Key companies in the market include Becton Dickinson and Company, Ypsomed, Novo Nordisk AS, Other, Sanofi, Eli Lilly and Company, Insulet Corporation, Medtronic PLC.
3. What are the main segments of the Europe Insulin Delivery Devices Market?
The market segments include Device, Technology, Components.
4. Can you provide details about the market size?
The market size is estimated to be USD 2.83 Million as of 2022.
5. What are some drivers contributing to market growth?
; The Rise in Global Prevalence of Cases of Obesity due to Modern Sedentary Lifestyles; Rise in Awareness and Disposable Income in Developed Economies.
6. What are the notable trends driving market growth?
Insulin Pump segment is expected to witness highest growth during the forecast period.
7. Are there any restraints impacting market growth?
; Highly Cost of Branded Products in Emerging Countries; Severe Adverse Associated with Medication Including Seizures. Suicidal Attempts and Even Death; Adoption of Traditional Yoga and Herbal Products.
8. Can you provide examples of recent developments in the market?
October 2022: Medtronic introduced a new program called My Insights, which is exclusively made for individuals using the MiniMed 770G system. Using an individual's data, My Insights relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. My Insights personalized recommendations are shared via a monthly email with educational content that is most relevant to what an individual may currently be experiencing. This is the first program in diabetes management that goes beyond generalized tips and instead shares personalized suggestions using data from an integrated pump system.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Insulin Delivery Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Insulin Delivery Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Insulin Delivery Devices Market?
To stay informed about further developments, trends, and reports in the Europe Insulin Delivery Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence